Medicine information
Uses & overview
LINALIGLIP DAPAMET 500 is a combination oral antidiabetic medicine from Steris Healthcare, formulated with Linagliptin 5 mg, Dapagliflozin 10 mg, and Metformin Hydrochloride Sustained Release (SR) 1000 mg. It is intended for physician-directed management of type 2 diabetes mellitus in suitable adults. Composition: Linagliptin – 5 mg Dapagliflozin – 10 mg Metformin Hydrochloride SR – 1000 mg Uses and Benefits: Helps manage blood glucose levels in adults with type 2 diabetes mellitus. Linagliptin helps regulate blood glucose by enhancing the activity of incretin hormones involved in glucose-dependent insulin release. Dapagliflozin helps the kidneys remove excess glucose through urine. Metformin SR helps reduce glucose production in the liver and improves the body's response to insulin. Combines three complementary mechanisms to support glycemic control alongside diet, exercise, and regular blood glucose monitoring. How LINALIGLIP DAPAMET 500 Works Linagliptin belongs to the DPP-4 inhibitor class and helps prolong the activity of incretin hormones that regulate insulin release and glucagon levels. Dapagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys. Metformin belongs to the biguanide class and primarily reduces glucose production in the liver while improving insulin sensitivity. Together, these ingredients support blood glucose management in suitable adults with type 2 diabetes. Why Choose LINALIGLIP DAPAMET 500 by Steris Healthcare? LINALIGLIP DAPAMET 500 by Steris Healthcare combines three antidiabetic ingredients in one tablet for convenient, physician-directed diabetes management. Treatment suitability depends on individual blood glucose levels, kidney function, other medical conditions, and concurrent medicines. This medicine is not intended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. Use only under medical supervision.
How to use
Take LINALIGLIP DAPAMET 500 exactly as prescribed by your physician. Follow the prescribed dose and timing, and take the tablet with food if directed by your doctor. Swallow the sustained-release tablet whole; do not crush, chew, or split it unless the product instructions specifically permit this. Do not change the dosage or discontinue treatment without medical advice. Your healthcare professional may monitor blood glucose levels and kidney function during treatment.
Storage
Store LINALIGLIP DAPAMET 500 Tablets in a cool, dry place, away from direct sunlight and moisture. Keep the medicine in its original packaging and follow the storage instructions printed on the product label. Keep out of reach of children. Do not use after the expiry date.
